| AFE | Amniotic fluid embolism |
| APO | Adverse pregnancy outcome |
| BMI | Body mass index |
| BP | Blood pressure |
| CAD | Coronary artery disease |
| CCLM | Clinical Chemistry and Laboratory Medicine |
| CHD | Congenital heart disease |
| CS | Cardiogenic shock |
| CVD | Cardiovascular disease |
| CVR | Cardiovascular risk |
| CVRF | Cardiovascular risk factor |
| CVS | Cardiovascular system |
| ECG | Electrocardiogram |
| ECMO | Extracorporeal membrane oxygenation |
| GDM | Gestational diabetes mellitus |
| HDP | Hypertensive disorders of pregnancy |
| HR | Hazard ratio |
| HTN | Hypertension |
| IABP | Intra-aortic balloon pump |
| ICD | International Classification of Diseases |
| ICU | Intensive care unit |
| IUGR | Intrauterine growth restriction |
| LDL | Low-density lipoprotein |
| LMWH | Low molecular weight heparin |
| LVM | Left ventricular mass |
| MACE | Major adverse cardiovascular events |
| MI | Myocardial infarction |
| NSTEMI | Non–ST-segment elevation myocardial infarction |
| NT-proBNP | N-terminal pro-B-type natriuretic peptide |
| OSF | Open Science Framework |
| PAAD | Pregnancy-associated arterial dissection |
| PE | Preeclampsia |
| PPCM | Peripartum cardiomyopathy |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| qPCR | Quantitative polymerase chain reaction |
| RR | Relative risk |
| SCAI | Society for Cardiovascular Angiography and Interventions |
| SCAD | Spontaneous coronary artery dissection |
| SBP | Systolic blood pressure |
| SMM | Severe maternal morbidity |
| STEMI | ST-segment elevation myocardial infarction |
| ST2/IL-33 | Suppression of tumorigenicity 2/Interleukin-33 receptor |
| T2DM | Type 2 diabetes mellitus |